Bukwang Pharm (003000) — Capital Reinvestment Ratio
Bukwang Pharm (003000) has a Capital Reinvestment Ratio of 0.28x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩10.03 Billion) in capital expenditures (₩2.80 Billion). See 003000 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bukwang Pharm Capital Reinvestment Ratio (2007–2024)
This chart tracks Bukwang Pharm's Capital Reinvestment Ratio across 10 annual periods. Check Bukwang Pharm investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Bukwang Pharm (2007–2024)
Year-by-year Capital Reinvestment Ratio for Bukwang Pharm from 2007 to 2024. For live market cap and broader valuation context, see Bukwang Pharm stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | ₩34.36 Billion | ₩2.61 Billion | ▼ -74.9% |
| 2022 | 0.30x | ₩16.46 Billion | ₩4.99 Billion | ▲ +924.3% |
| 2021 | 0.03x | ₩26.52 Billion | ₩785.05 Million | ▼ -98.9% |
| 2020 | 2.65x | ₩723.17 Million | ₩1.92 Billion | ▲ +387.4% |
| 2018 | 0.54x | ₩6.82 Billion | ₩3.71 Billion | ▲ +3.8% |
| 2017 | 0.52x | ₩8.56 Billion | ₩4.49 Billion | ▲ +17.8% |
| 2015 | 0.44x | ₩10.30 Billion | ₩4.58 Billion | ▲ +317.6% |
| 2014 | 0.11x | ₩27.86 Billion | ₩2.97 Billion | ▲ +3.8% |
| 2013 | 0.10x | ₩36.52 Billion | ₩3.74 Billion | ▼ -86.2% |
| 2007 | 0.74x | ₩27.87 Billion | ₩20.69 Billion | — |